The DOI matches its Crossref record; 272 of the 272 references it cites were found in a registry or an index.
Lung cancer: Biology and treatment options
Open accessAbstract
Lung cancer remains the leading cause of cancer mortality in men and women in the U.S. and worldwide. About 90% of lung cancer cases are caused by smoking and the use of tobacco products. However, other factors such as radon gas, asbestos, air pollution exposures, and chronic infections can contribute to lung carcinogenesis. In addition, multiple inherited and acquired mechanisms of susceptibility to lung cancer have been proposed. Lung cancer is divided into two broad histologic classes, which grow and spread differently: small-cell lung carcinomas (SCLC) and non-small cell lung carcinomas (NSCLC). Treatment options for lung cancer include surgery, radiation therapy, chemotherapy, and targeted therapy. Therapeutic-modalities recommendations depend on several factors, including the type and stage of cancer. Despite the improvements in diagnosis and therapy made during the past 25 years, the prognosis for patients with lung cancer is still unsatisfactory. The responses to current standard therapies are poor except for the most localized cancers. However, a better understanding of the biology pertinent to these challenging malignancies, might lead to the development of more efficacious and perhaps more specific drugs. The purpose of this review is to summarize the recent developments in lung cancer biology and its therapeutic strategies, and discuss the latest treatment advances including therapies currently under clinical investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–272 of 272
The Tumor Microenvironment in Non–Small-Cell Lung Cancer
Graves, E. E., Maity, A. M., & Le, Q. (2010) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.01.003 · Cited by 142
Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy
Varadhachary, A., Wolf, J. S., Petrak, K., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20271 · Cited by 138
Bronte, V. (2009) · European Journal of Immunology · doi:10.1002/eji.200939892 · Cited by 137
Serum Interleukin-10 Levels as a Prognostic Factor in Advanced Non-small Cell Lung Cancer Patients
Vita, F. D., Orditura, M., Galizia, G., Romano, C. P., Roscigno, A., Lieto, E., & Catalano, G. (2000) · CHEST Journal · doi:10.1378/chest.117.2.365 · Cited by 135
Richards, P., & McKissock, W. (1963) · BMJ · doi:10.1136/bmj.1.5322.15 · Cited by 133
Class effects of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
Giles, F. J., O'Dwyer, M. E., & Swords, R. T. (2009) · Leukemia · doi:10.1038/leu.2009.111 · Cited by 127
Fu, J. L., Malm, I., Kadayakkara, D. K. K., Levitsky, H., Pardoll, D. M., & Kim, Y. J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2685 · Cited by 127
Chiappori, A. A., Soliman, H., Janssen, W. E., Antonia, S. J., & Gabrilovich, D. I. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2010.484801 · Cited by 126
Zatloukal, P., Heo, D. S., Park, K., Kang, J., Butts, C., Bradford, D. S., Graziano, S. L., Huang, B., & Healey, D. I. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.15_suppl.8071 · Cited by 125
Krug, L. M., Dao, T., Brown, A. B., Maslak, P. G., Travis, W. D., Bekele, S., Korontsvit, T., Zakhaleva, V., Wolchok, J. D., Yuan, J. D., et al. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0871-8 · Cited by 124
Lin, C., Chen, X., Li, M., Liu, J., Qi, X., Yang, W., Zhang, H., Cai, Z., Dai, Y., & Ouyang, X. (2015) · Clinical Lung Cancer · doi:10.1016/j.cllc.2015.02.002 · Cited by 121
Immunotherapies for non-small-cell lung cancer and mesothelioma
Thomas, A., & Hassan, R. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70126-2 · Cited by 121
Jassem, J., Langer, C. J., Karp, D. D., Mok, T. S. K., Benner, R. J., Green, S., Park, K., Novello, S., Strausz, J., & Gualberto, A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.7500 · Cited by 121
Tumor microenvironment is multifaceted
Sautès‐Fridman, C., Cherfils‐Vicini, J., Damotte, D., Fisson, S., Fridman, W. H., Cremer, I., & Dieu‐Nosjean, M. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9279-y · Cited by 118
PRAME expression and clinical outcome of breast cancer
Epping, M. T., Hart, A. A. M., Glas, A. M., Krijgsman, O., & Bernards, R. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604494 · Cited by 118
Maïo, M. D., Perrone, F., Chiodini, P., Gallo, C., Camps, C., Schuette, W., Quoix, É., Tsai, C., & Gridelli, C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.8251 · Cited by 118
Health-Related Disparities: Influence of Environmental Factors
Olden, K., & White, S. L. (2005) · Medical Clinics of North America · doi:10.1016/j.mcna.2005.02.001 · Cited by 116
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients
Petrovic, M. D., Čekerevac, I., Lazić, Z., & Zdravković, V. (2013) · European Respiratory Journal · doi:10.1183/13993003/erj.42.suppl_57.p2916 · Cited by 112
Hamaji, M., Allen, M. S., Cassivi, S. D., Deschamps, C. C., Nichols, F. C., Wigle, D. A., & Shen, K. R. (2013) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.12.051 · Cited by 110
Peterson, P. M., Park, K., Fossella, F. V., Gatzemeier, U., John, W. J., & Scagliotti, G. V. (2007) · Journal of Thoracic Oncology · doi:10.1097/01.jto.0000284677.33344.62 · Cited by 110
Shi, A. A., Digumarthy, S. R., Temel, J. S., Halpern, E. F., Kuester, L. B., & Aquino, S. L. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)31569-0 · Cited by 108
Doddoli, C., D’Journo, X. B., Pimpec‐Barthes, F. L., Dujon, A., Foucault, C., Thomas, P. A., & Riquet, M. (2005) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2005.03.088 · Cited by 106
Guerrieri, M., Wong, K., Ryan, G. F., Millward, M. J., Quong, G., & Ball, D. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.02.019 · Cited by 100
Identification of genes associated with non-small-cell lung cancer promotion and progression
Banković, J., Stojšić, J. M., Jovanović, D. J., Andjelković, T., Milinković, V., Ruždijić, S., & Tanić, N. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.04.010 · Cited by 99
Neuhaus, T., Ko, Y., Müller, R.-P., Grabenbauer, G. G., Hedde, J.-P., Schueller, H., Köcher, M., Stier, S., & Fietkau, R. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604835 · Cited by 99
Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial.
Navari, R. M., & Brenner, M. C. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-009-0739-7 · Cited by 99
Borasio, P., Berruti, A., Billè, A., et al. (2008) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2007.09.044 · Cited by 99
von Pawel, J., Harvey, J. H., Spigel, D. R., Dediu, M., Reck, M., Cebotaru, C. L., Humphreys, R. C., Gribbin, M., Fox, N. L., & Camidge, D. R. (2014) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.12.005 · Cited by 99
Chemotherapy of brain metastases from lung carcinoma
Ushio, Y., Arita, N., Hayakawa, T., et al. (1991) · Neurosurgery · doi:10.1097/00006123-199102000-00005 · Cited by 98
Stahel, R. A., Weder, W., Lievens, Y. N., & Felip, E. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq173 · Cited by 98
Vorinostat increases carboplatin and paclitaxel activity in non‐small cell lung cancer cells
Owonikoko, T. K., Ramalingam, S. S., Kanterewicz, B. I., Balius, T. E., Belani, C. P., & Hershberger, P. A. (2009) · International Journal of Cancer · doi:10.1002/ijc.24759 · Cited by 97
New TNM classification for non-small-cell lung cancer
Tanoue, L. T., & Detterbeck, F. C. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/era.09.11 · Cited by 96
Moore, A. M., Einhorn, L. H., Estes, D., Govindan, R., Axelson, J., Vinson, J., Breen, T., Yu, M., & Hanna, N. H. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2005.12.002 · Cited by 92
Ready, N., Dudek, A. Z., Pang, H., Hodgson, L. D., Graziano, S. L., Green, M. R., & Vokes, E. E. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.6923 · Cited by 91
Chemotherapy of Brain Metastases from Lung Carcinoma: A Controlled Randomized Study
Ushio, Y., Arita, N., Hayakawa, T., et al. (1991) · Neurosurgery · doi:10.1227/00006123-199102000-00005 · Cited by 91
Rodríguez, P. C., Rodríguez, G., González, G., & Lage, A. (2010) · MEDICC Review · doi:10.37757/mr2010.v12.n1.4 · Cited by 89
Prevalence and prognostic and predictive relevance of PRAME in breast cancer
Doolan, P., CLYNES, M. M., Kennedy, S., Mehta, J. P., Crown, J. P., & O’Driscoll, L. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9643-3 · Cited by 81
POSTOPERATIVE RADIOTHERAPY OF NON-SMALL CELL LUNG CANCER
Фанисович, М. Ф., & Sharipova, N. S. (2015) · Malignant tumours · doi:10.18027/2224-5057-2014-3-91-96 · Cited by 77
Resection of chest wall invasion in patients with non-small cell lung cancer
MATSUOKA, H. (2004) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2004.07.038 · Cited by 75
Paz-Ares, L. G., Bálint, B., Boer, R. H. D., van Meerbeeck, J. P., Wierzbicki, R. F., SOUZA, P. D., Galimi, F., Haddad, V., Sabin, T., Hei, Y.-J., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31827ce554 · Cited by 74
Epigenetic regulation of PRAME gene in chronic myeloid leukemia
Román‐Gómez, J., Jiménez‐Velasco, A., Agirre, X., Castillejo, J. A., Navarro, G., José‐Eneriz, E. S., Gárate, L., Cordeu, L., Cervantes, F., Prósper, F., et al. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.02.016 · Cited by 70
Digumarti, R., Wang, Y., Raman, G. S., Doval, D. C., Advani, S. H., Julka, P. K., Parikh, P. M., Patil, S., Nag, S. M., Madhavan, J., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182156250 · Cited by 69
Postoperative radiotherapy for non-small cell lung cancer
PORT Meta-analysis Trialists Group (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002142.pub2 · Cited by 68
Baratelli, F. E., Lee, J. M., Hazra, S., Lin, Y., Walser, T. C., Schaue, D., Pak, P. S., Elashoff, D. A., Reckamp, K. L., Zhang, L., et al. (2010) · PubMed Central · Cited by 67
Zhang, W., Peyton, M., Xie, Y., Soh, J., Minna, J. D., Gazdar, A. F., & Frenkel, E. P. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318194fae7 · Cited by 66
Jin, H., Yang, R., Ross, J., Fong, S., Carano, R. A. D., Tótpál, K., Lawrence, D. A., Zheng, Z., Koeppen, H., Stern, H. M., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0670 · Cited by 65
Bria, E., Cuppone, F., Ciccarese, M., Nisticò, C., Facciolo, F., Milella, M., Izzo, F., Terzoli, E., Cognetti, F., & Giannarelli, D. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.07.003 · Cited by 64
Sanford, M., & Scott, L. J. (2009) · Drugs · doi:10.2165/10489100-000000000-00000 · Cited by 60
Gitlitz, B. J., Moon, J., Glisson, B. S., Reimers, H. J., Bury, M. J., Floyd, J. D., Schulz, T. K., Sundaram, P. K., Ho, C., & Gandara, D. R. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181f0bd78 · Cited by 58
The PIK3CA Gene as a Mutated Target for Cancer Therapy
Gustin, J. P., Cosgrove, D., & Park, B. H. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908786733504 · Cited by 58
Vansteenkiste, J., Zielinski, M., Dahabreh, I. J., Linder, A., Lehmann, F., Gruselle, O., Therasse, P., Louahed, J., & Brichard, V. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.7501 · Cited by 58
Beyond the Standard of Care: A Review of Novel Immunotherapy Trials for the Treatment of Lung Cancer
Hall, R. D., Gray, J. E., & Chiappori, A. (2013) · Cancer Control · doi:10.1177/107327481302000105 · Cited by 57
Adjuvant Therapy in Non-Small Cell Lung Cancer: Current and Future Directions
Sangha, R. S., Price, J., & Butts, C. A. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0186 · Cited by 56
Tessema, M., Yingling, C. M., Thomas, C. L., Klinge, D. M., Bernauer, A. M., Liu, Y., Dacic, S., Siegfried, J. M., Dahlberg, S. E., Schiller, J. H., et al. (2011) · Oncogene · doi:10.1038/onc.2011.577 · Cited by 55
Exciting New Targets in Lung Cancer Therapy: ALK, IGF-1R, HDAC, and Hh
Neal, J. W., & Sequist, L. V. D. (2010) · Current Treatment Options in Oncology · doi:10.1007/s11864-010-0120-6 · Cited by 53
Lee, J. K., Park, H. S., Kim, D., Kulig, K., Kim, T. M., Lee, S., Jeon, Y., Chung, D. H., Heo, D. S., Kim, W., et al. (2011) · Cancer · doi:10.1002/cncr.26668 · Cited by 52
Singer, C. F., Köstler, W. J., & Hudelist, G. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.02.003 · Cited by 51
Multitargeted anti-angiogenic agents and NSCLC: Clinical update and future directions
Ellis, P. M., & Alsaleh, K. A. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.02.004 · Cited by 49
Spigel, D. R., Reckamp, K. L., Rizvi, N. A., Poddubskaya, E. V., West, H., Eberhardt, W., Baas, P., Antonia, S. J., Płużański, A., Vokes, E. E., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.33.15_suppl.8009 · Cited by 46
Malignant mesothelioma of the pleural space.
Grondin, S. C., & Sugarbaker, D. J. (1999) · PubMed · Cited by 46
Epidemiology of malignant mesothelioma in Australia
Musk, A. W., & de Klerk, N. H. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.04.010 · Cited by 45
Mariya, Y., Sekizawa, G., Matsuoka, Y., Seki, H., & Sugawara, T. (2010) · Journal of Radiation Research · doi:10.1269/jrr.90130 · Cited by 36
Madrid, A. M. L., Campbell, N. P., Smith, S. M., Cohn, S. L., & Salgia, R. (2012) · Targeted Oncology · doi:10.1007/s11523-012-0227-8 · Cited by 33
Antiapoptotic Signaling Pathways in Non–Small-Cell Lung Cancer: Biology and Therapeutic Strategies
Haura, E. B., Cress, W. D., Chellappan, S., Zheng, Z., & Bepler, G. (2004) · Clinical Lung Cancer · doi:10.3816/clc.2004.n.025 · Cited by 32
Pas, T. M. D., Giovannini, M., Rescigno, M., Catania, C., Toffalorio, F., Spitaleri, G., Delmonte, A., Barberis, M. C. P., Spaggiari, L., Solli, P., et al. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.12.005 · Cited by 31
Optimizing Outcomes for Patients With Advanced Disease in Chronic Myelogenous Leukemia
Giles, F. J., DeAngelo, D. J., Baccarani, M., Deininger, M. W., Guilhot, F., Hughes, T. P., Mauro, M. J., Radich, J. P., Ottmann, O. G., & Cortes, J. E. (2008) · Seminars in Oncology · doi:10.1053/j.seminoncol.2007.12.002 · Cited by 30
Brawley, O. W. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.7077 · Cited by 26
Hitoshi, Y., Lin, N., Payan, D. G., & Markovtsov, V. V. (2010) · International Journal of Hematology · doi:10.1007/s12185-010-0531-y · Cited by 25
Emerging New Agents for the Management of Patients with Non-Small Cell Lung Cancer
Capelletto, E., & Novello, S. (2012) · Drugs · doi:10.2165/1163028-s0-000000000-00000 · Cited by 25
Dendritic cell vaccination in malignant pleural mesothelioma: A phase I/II study.
Berneman, Z. N., Germonpré, P. R., Huizing, M. T., de Velde, A. V., Nijs, G., Stein, B., Tendeloo, V. F. V., Lion, E., Smits, E., & Anguille, S. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.7583 · Cited by 13
Zhang, Y., Li, X., Chen, Z., & Bepler, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091186 · Cited by 10
Predictive and Prognostic Value of ALK Gene Rearrangement in Non- Small Cell Lung Cancer
Wang, K. K. Y. (2014) · Epidemiology Open Access · doi:10.4172/2161-1165.1000146 · Cited by 6
Cited by
miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis
Condrat, C. E., Thompson, D. C., Barbu, M. G., Bugnar, O. L., Boboc, A., Cretoiu, D., Suciu, N., Cretoiu, S. M., & Voinea, S. C. (2020) · Cells · doi:10.3390/cells9020276 · Cited by 1,344
Abdelaziz, H. M., Gaber, M., Abd-Elwakil, M. M., Mabrouk, M. T., Elgohary, M. M., Kamel, N. M., Kabary, D. M., Freag, M. S., Samaha, M. W., Mortada, S. M., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.036 · Cited by 409
Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
Larionova, I., Tuguzbaeva, G., Ponomaryova, A., Stakheyeva, M., Cherdyntseva, N., Pavlov, V., Choinzonov, E., & Kzhyshkowska, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.566511 · Cited by 392
Does air pollution play a role in infertility? a systematic review.
Carré, J., Gatimel, N., Moreau, J., Parinaud, J., & Léandri, R. (2017) · Environmental Health · doi:10.1186/s12940-017-0291-8 · Cited by 379
Ferroptosis in health and disease
Berndt, C., Alborzinia, H., Amen, V. S., Ayton, S., Barayeu, U., Bartelt, A., Bayir, H., Bebber, C. M., Birsoy, K., Böttcher, J. P., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103211 · Cited by 334
Metadata
- Authors
- Lemjabbar-Alaoui, H., Hassan, O. U., Yang, Y.-W., & Buchanan, P.
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 1856
- Issue
- 2
- Pages
- 189-210
- ISSN
- 0304-419X (ISSN-L)
- OpenAlex
- W1874454018
- Cited by
- 1,014
- References
- 272
- FWCI
- 26.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.